CUE Cue Biopharma
- 0.636
- -0.024-3.65%
- 0.636
- -0.001-0.08%
Cue Biopharma News
Cue Biopharma | 8-K: Current report
Cue Biopharma | 4: Statement of changes in beneficial ownership of securities-Officer Levisetti Matteo
Cue Biopharma | 4: Statement of changes in beneficial ownership of securities-Officer Suri Anish
Cue Biopharma | 4: Statement of changes in beneficial ownership of securities-Director Fox Michael J
Cue Biopharma | 4: Statement of changes in beneficial ownership of securities-Officer Sandercock Colin
Cue Biopharma | 3: Initial statement of beneficial ownership of securities-Director Fox Michael J
Cue Biopharma | 4: Statement of changes in beneficial ownership of securities-Officer Millar Kerri-Ann
Cue Biopharma | DEFA14A: Others
Cue Biopharma | 10-Q: Q1 2024 Earnings Report
Cue Biopharma | 8-K: Cue Biopharma Reports First Quarter 2024 Financial Results and Recent Business Highlights
Cue Biopharma | DEF 14A: Definitive information statements
Cue Biopharma | DEFA14A: Others
Cue Biopharma | ARS: Annual Report to Security Holders
Cue Biopharma | 10-K: FY2023 Annual Report
Cue Biopharma | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
Cue Biopharma | SC 13G: Statement of acquisition of beneficial ownership by individuals
Cue Biopharma | 4: Statement of changes in beneficial ownership of securities-Officer PASSERI DANIEL R
Cue Biopharma | 4: Statement of changes in beneficial ownership of securities-Officer Millar Kerri-Ann
Cue Biopharma | 4: Statement of changes in beneficial ownership of securities-Officer Suri Anish
Cue Biopharma | 4: Statement of changes in beneficial ownership of securities-Officer Sandercock Colin
Analysis
Price Target
No Data
